Mergers and acquisitions

Being for the $11.9bn benefit of investors of Kite: Gilead jumps into CAR-T

Image: iStock/roberthyrons

Gilead will add a late-stage CAR T-cell candidate and a facility in California capable of treating 5,000 patients per year through the $11.9bn deal.

Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization. (Image: iStock/macgyverhh)

AMRI set to be acquired by private equity


How Thermo Fisher buying Patheon could simplify pharma supply chains

Image: iStock/Bigandt_Photography

Looking to gain a foothold in Ireland? MSD puts shuttered site up for sale

Image: iStock/designer491

Thermo Fisher bags single-use bioreactor tech partner Finesse

Image: iStock/mindscanner

J&J buying Actelion for $30bn, but should CMOs be concerned?

Image: iStock/AlexRaths

A 'small sale for MannKind' as it offloads Californian HQ and production site

JP Morgan Conference: Trumpcare, moonshots and M&A

JP Morgan Conference: Trumpcare, moonshots and M&A

Image: iStock/rudall30

Out with the old, in with the new? Lonza sells peptide biz, Recipharm adds Indian ops

Image: iStock/maxsattana

Catalent: smaller firms set to struggle in capital intensive CMO space

More Mergers and acquisitions